-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprea Therapeutics announces annual shareholder meeting via webcast

PUBT·04/20/2026 10:31:27
Listen to the news
Aprea Therapeutics announces annual shareholder meeting via webcast
  • Aprea Therapeutics will hold its 2026 annual meeting of stockholders virtually on June 16, 2026.
  • Shareholders will vote on election of three Class I directors to three-year terms expiring in 2029.
  • Ballot includes ratification of EisnerAmper as independent registered public accounting firm for fiscal 2026.
  • Investors will consider an amendment to authorize a reverse stock split at a ratio between 1-for-3 and 1-for-8.
  • Agenda also includes advisory votes on executive compensation, say-on-pay frequency, and potential adjournment to solicit additional proxies for reverse split proposal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprea Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-045158), on April 20, 2026, and is solely responsible for the information contained therein.